Recent Updates
Recently added Catalysts
BIIB

“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong

Key Takeaway: “LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong

Full Press Release Details

“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong.
Last updated: Jul 10, 2024